Fulton Breakefield Broenniman’s iShares iBonds Dec 2033 Term Corporate ETF IBDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
58,803
+8,153
+16% +$213K 0.1% 82
2025
Q4
$1.32M Buy
50,650
+3,407
+7% +$89.3K 0.08% 85
2025
Q3
$1.24M Buy
47,243
+4,315
+10% +$112K 0.08% 90
2025
Q2
$1.11M Buy
42,928
+33,078
+336% +$839K 0.08% 91
2025
Q1
$252K Buy
9,850
+1,490
+18% +$37.7K 0.02% 158
2024
Q4
$210K Buy
+8,360
New +$214K 0.02% 184

Other funds holding IBDY

Fulton Breakefield Broenniman's IBDY Position: Q1 2026 in Review

Fulton Breakefield Broenniman increased its iShares iBonds Dec 2033 Term Corporate ETF (IBDY) stake by 16% in Q1 2026, buying an estimated $213K and bringing the position to 58,803 shares worth $1.52M. The position accounts for 0.1% of the portfolio, ranked #82.

Fulton Breakefield Broenniman first reported a position in IBDY in Q4 2024 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold IBDY as of Q1 2026.

  • Fulton Breakefield Broenniman held 58,803 shares of iShares iBonds Dec 2033 Term Corporate ETF worth $1.52M as of Q1 2026.
  • Fulton Breakefield Broenniman bought 8,153 iShares iBonds Dec 2033 Term Corporate ETF shares in Q1 2026, an estimated $213K.
  • iShares iBonds Dec 2033 Term Corporate ETF made up 0.1% of Fulton Breakefield Broenniman's portfolio in Q1 2026, its #82 holding.
  • Fulton Breakefield Broenniman first reported a position in iShares iBonds Dec 2033 Term Corporate ETF in Q4 2024 and has held it in 6 quarters since.
  • 161 funds tracked by Wall St. Rank held iShares iBonds Dec 2033 Term Corporate ETF as of Q1 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q1 2026, filed 27 Apr 2026.